GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM (CAS:PRO) » Definitions » Beneish M-Score

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM (CAS:PRO) Beneish M-Score : 7.69 (As of Mar. 26, 2025)


View and export this data going back to 2007. Start your Free Trial

What is PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 7.69 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Beneish M-Score or its related term are showing as below:

CAS:PRO' s Beneish M-Score Range Over the Past 10 Years
Min: -2.19   Med: -1.72   Max: 38.08
Current: 7.69

During the past 8 years, the highest Beneish M-Score of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM was 38.08. The lowest was -2.19. And the median was -1.72.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Beneish M-Score Historical Data

The historical data trend for PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Beneish M-Score Chart

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial -2.15 -1.92 38.08 -1.52 7.69

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.52 - 7.69 -

Competitive Comparison of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Beneish M-Score falls into.


';

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.4826+0.528 * 1.1852+0.404 * 0.7066+0.892 * 1.1432+0.115 * 83.0435
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * 0.057792-0.327 * 1.2602
=7.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was MAD317.8 Mil.
Revenue was MAD805.5 Mil.
Gross Profit was MAD359.2 Mil.
Total Current Assets was MAD663.8 Mil.
Total Assets was MAD984.5 Mil.
Property, Plant and Equipment(Net PPE) was MAD310.7 Mil.
Depreciation, Depletion and Amortization(DDA) was MAD0.0 Mil.
Selling, General, & Admin. Expense(SGA) was MAD0.0 Mil.
Total Current Liabilities was MAD369.5 Mil.
Long-Term Debt & Capital Lease Obligation was MAD13.5 Mil.
Net Income was MAD56.9 Mil.
Gross Profit was MAD0.0 Mil.
Cash Flow from Operations was MAD0.0 Mil.
Total Receivables was MAD187.5 Mil.
Revenue was MAD704.6 Mil.
Gross Profit was MAD372.5 Mil.
Total Current Assets was MAD539.2 Mil.
Total Assets was MAD762.9 Mil.
Property, Plant and Equipment(Net PPE) was MAD212.7 Mil.
Depreciation, Depletion and Amortization(DDA) was MAD0.4 Mil.
Selling, General, & Admin. Expense(SGA) was MAD0.0 Mil.
Total Current Liabilities was MAD235.5 Mil.
Long-Term Debt & Capital Lease Obligation was MAD0.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(317.801 / 805.516) / (187.51 / 704.64)
=0.394531 / 0.266108
=1.4826

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(372.466 / 704.64) / (359.242 / 805.516)
=0.52859 / 0.445977
=1.1852

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (663.808 + 310.728) / 984.532) / (1 - (539.221 + 212.683) / 762.866)
=0.010153 / 0.014369
=0.7066

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=805.516 / 704.64
=1.1432

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.407 / (0.407 + 212.683)) / (0.007 / (0.007 + 310.728))
=0.00191 / 2.3E-5
=83.0435

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 805.516) / (0 / 704.64)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((13.499 + 369.483) / 984.532) / ((0 + 235.478) / 762.866)
=0.388999 / 0.308675
=1.2602

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(56.898 - 0 - 0) / 984.532
=0.057792

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM has a M-score of 7.69 signals that the company is likely to be a manipulator.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Beneish M-Score Related Terms

Thank you for viewing the detailed overview of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Business Description

Traded in Other Exchanges
N/A
Address
Rue N 7, ZI du Sahel, BP 96/97, Berrechid, Had Soualem, MAR, 26400
PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM is engaged in production, marketing, import and export of pharmaceuticals, parapharmaceuticals, dermopharmaceuticals and cosmetics.